| Authors: |
Webster JM; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, United States of America., Yang YT; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, United States of America., Miller AT; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Zane A; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Scholz K; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Stone WJ; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Mudium N; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Corbin-Stein NJ; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, United States of America., Won WJ; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Stoll AC; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Greathouse KM; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Cooper NH; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Long LF; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Manuel PN; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Herskowitz JH; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Yacoubian TA; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America., Tyrrell DJ; University of Alabama at Birmingham, Department of Pathology, Division of Molecular and Cellular Pathology, Birmingham, AL 35294, United States of America., Sandoval IM; Barrow Neurological Institute, Department of Translational Neuroscience; Phoenix, AZ, 85013., Manfredsson FP; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, United States of America; Barrow Neurological Institute, Department of Translational Neuroscience; Phoenix, AZ, 85013., Kordower JH; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, United States of America; Arizona State University, ASU-Banner Neurodegenerative Disease Research Center, Bio-design Institute, Tempe, AZ 85281, United States of America., Harms AS; University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL 35294, United States of America; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, United States of America. Electronic address: anharms@uab.edu. |
